Prostate cancer screening--is the controversy resolved?
作者信息
Norcross W A, Ganiats T G
出版信息
West J Med. 1995 Jul;163(1):65-6.
Abstract
摘要
相似文献
1
Prostate cancer screening--is the controversy resolved?前列腺癌筛查——争议解决了吗？
West J Med. 1995 Jul;163(1):65-6.
2
Prostate-specific antigen and prostate cancer prognosis.前列腺特异性抗原与前列腺癌预后
J Natl Cancer Inst. 2006 Nov 1;98(21):1509-10. doi: 10.1093/jnci/djj455.
3
4
[Prostatic cancer screening].[前列腺癌筛查]
Ugeskr Laeger. 2002 Jan 7;164(2):155-7.
5
Screening for prostate cancer--the controversy that refuses to die.前列腺癌筛查——经久不息的争议。
N Engl J Med. 2009 Mar 26;360(13):1351-4. doi: 10.1056/NEJMe0901166. Epub 2009 Mar 18.
6
Prostatic cancer and BPH.前列腺癌和良性前列腺增生。
Postgrad Med. 1994 Jul;96(1):24-5.
7
An evaluation of prostate-specific antigen as a screening test for prostate cancer.前列腺特异性抗原作为前列腺癌筛查检测方法的评估。
Arch Intern Med. 1993 Nov 22;153(22):2529-37.
8
Prostate cancer: 4. Screening.前列腺癌：4. 筛查。
CMAJ. 1998 Oct 20;159(8):968-72.
9
Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.关于前列腺特异性抗原筛查的争议已从死亡率问题转向过度治疗问题。
Int J Urol. 2009 Sep;16(9):711-12.
10
[Prostate-specific antigen as a tumor marker of prostate carcinoma].[前列腺特异性抗原作为前列腺癌的肿瘤标志物]
Ned Tijdschr Geneeskd. 1999 Aug 21;143(34):1733-8.
本文引用的文献
1
Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers.定义并更新美国癌症协会癌症相关检查指南：前列腺癌和子宫内膜癌。
CA Cancer J Clin. 1993 Jan-Feb;43(1):42-6. doi: 10.3322/canjclin.43.1.42.
2
Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993).
Urology. 1993 Dec;42(6):622-9. doi: 10.1016/0090-4295(93)90524-e.
3
Quality-of-life outcomes in men treated for localized prostate cancer.接受局限性前列腺癌治疗的男性的生活质量结果。
JAMA. 1995 Jan 11;273(2):129-35. doi: 10.1001/jama.273.2.129.
4
PSA screening for asymptomatic prostate cancer: truth in advertising.
J Fam Pract. 1993 Nov;37(5):432-6.
Zotero 插件